Acinar cell cystadenocarcinoma is a rare malignant epithelial neoplasm of the pancreas with a diffusely cystic, gross architecture in which the cysts are lined with neoplastic epithelial cells that demonstrate evidence of pancreatic exocrine enzyme production. This is the 10th case that has been reported in the literature. A 77-year-old male complaining of left hypochondrial pain was referred to our hospital for treatment of a pancreatic tumor. A huge, honeycombstructured tumor was detected in the pancreatic tail. Distal pancreatectomy with total resection of the residual stomach and partial resection of the transverse colon were performed. Microscopically, there were variably sized cystic lesions in the tumor. Immunohistochemical examinations revealed that tumor cells were positive for alpha 1-antichymotrypsin and alpha 1-trypsin, showing that tumor cells had features of pancreatic acinar cells. Thus, the tumor was diagnosed as acinar cell cystadenocarcinoma. Herein, we report a rare case with acinar cell cystadenocarcinoma, which is the 10th case reported in the literature based on a Pub-Med search. We managed to resect the tumor completely by distal pancreatectomy with Case Aoto et al.: Acinar Cell Cystadenocarcinoma of the Pancreas 505 total resection of the residual stomach and partial resection of the transverse colon. The patient is still alive 26 months after surgery without any recurrence after 1 year of adjuvant chemotherapy with S-1.
Introduction
Acinar cells make up the bulk of the pancreas, whereas pancreatic neoplasms exhibiting predominantly acinar differentiation are relatively uncommon. Almost all acinar neoplasms of the pancreas are malignant. The most common type (more than 90%) of carcinoma of the pancreas is infiltrating ductal adenocarcinoma. Acinar cell carcinoma accounts for 1-2% of pancreatic neoplasms in adults and 15% of pediatric neoplasms, and most patients are adults [1] . Acinar cell cystadenocarcinoma is a rare malignant epithelial neoplasm of the pancreas with a diffusely cystic, gross architecture in which the cysts are lined with neoplastic epithelial cells that demonstrate evidence of pancreatic exocrine enzyme production [1] , and only 9 cases have been reported so far [2] [3] [4] [5] [6] [7] [8] [9] [10] . The cystic structure, which is separated by a thin fibrous septum, looks sponge-like. The clinicopathological features of pancreatic acinar cell cystadenocarcinoma remain to be elucidated, and therapeutic strategies for the disease have not yet been developed. Herein, we report a case with acinar cystadenocarcinoma of the pancreas complaining of abdominal pain.
Case Presentation
A 77-year-old male complaining of left hypochondrial pain was referred to our hospital for treatment of a pancreatic tumor. His medical history demonstrated distal gastrectomy with Billroth type II reconstruction for a gastric carcinoma 30 years ago (poorly differentiated adenocarcinoma, submucosal infiltration, n0, and stage I). Carbohydrate antigen 19-9 was elevated to 582.0 U/ml, but there were no other abnormalities in blood chemical analyses. Abdominal computed tomography revealed a huge tumor (123 × 104 × 86 mm in size), compressing the surrounding organs, in the pancreatic tail ( Fig. 1a) . A magnetic resonance imaging enhanced with gadolinium revealed a well-margined, honeycomb-structured tumor with a high-intensity area in the tumor on T2-weighted image, which was estimated to be a fluid collection ( Fig. 1b ). Abnormal accumulations with a maximum standardized uptake value of 7.1 were detected in 18 F-fluorodeoxyglucose-positron emission computed tomography ( Fig. 1c ).
Distal pancreatectomy with total resection of the residual stomach and partial resection of the transverse colon were performed and reconstructed in a Roux-en-Y fashion. The resected specimen is shown in Figure 2 . A cut surface of the tumor looked like a sponge. Pathological findings showed variably sized cystic lesions containing eosinophilic substances, lined with flat or cubic eosinophilic cells with granules in the cytosol (Fig. 3a, b ). Immunohistochemical analyses revealed that tumor cells were positive for alpha 1-antichymotrypsin ( Fig. 3c ) and alpha 1-trypsin, showing that tumor cells had features of pancreatic acinar cells. The tumor invaded into the spleen without lymph node metastasis. The tumor was diag-nosed as acinar cell cystadenocarcinoma, with pT3, pN0, cM0, and final stage III using the TNM classification of the Union for International Cancer Control, 7th edition.
The patient was discharged on the 9th day after surgery with an uneventful course. We prescribed S-1 (80 mg/body) as adjuvant chemotherapy for 1 year. He is still alive at 26 months after surgery without recurrent disease.
Discussion
To the best of our knowledge, this is the 10th case of acinar cell cystadenocarcinoma reported in the literature (7 male cases and 3 female cases) as shown in Table 1 . The average age of the patients was 53.2 years (range: 4-77), and the mean tumor size was 17 cm at the time of diagnosis. Six cases were complaining of abdominal pain. The involved portion of the pancreas was the head in 3 cases, the body in 1 case, the tail in 2 cases, and both the body and the tail in 3 cases. Five cases developed hepatic metastasis, whereas 2 cases suffered from peritoneal dissemination after surgery. Three cases died 2, 13, and 37 months after surgery, respectively. Six patients were alive at the time of the report, with a mean survival time of 14.3 months. Acinar cell cystadenoma/adenocarcinoma should be distinguished from serous cystadenoma and neuroendocrine tumor. It is requisite for a diagnosis of acinar cell cystadenocarcinoma that tumor cells contain pancreatic exocrine enzymes without markers showing a differentiation into neurons in immunohistochemistry. Microscopic features of acinar cell cystadenoma/adenocarcinoma comprise acinar-like formation and eosinophilic cytosol without abundant glycogen. Other cystic tumors of the pancreas are usually excluded by absence of mucinous epithelium. Our case was confirmed to be acinar cell cystadenocarcinoma by immunohistochemical analyses for alpha 1-antichymotrypsin and alpha 1-trypsin which are pancreatic exocrine enzymes. The number of cases with acinar cell cystadenocarcinoma reported so far is so small that a standard therapeutic strategy has not yet been established. However, surgical removal is the only way to cure the disease.
Conclusions
We reported a rare case with acinar cell cystadenocarcinoma, which is the 10th case reported in the literature based on a PubMed search. We managed to resect the tumor completely by distal pancreatectomy with total resection of the residual stomach and partial resection of the transverse colon. The patient is still alive at 26 months after surgery without any recurrence after 1 year of adjuvant chemotherapy with S-1.
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